The global Cytomegalovirus (CMV) Diagnostic market is projected to grow from US$ 830 million in 2024 to US$ 1170.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.

Cytomegalovirus (CMV) Diagnostic Market

Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to the infection of the virus that stays in an individual’s body throughout his life.

Market Analysis and Insights: Global Cytomegalovirus (CMV) Diagnostic Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Cytomegalovirus (CMV) Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cytomegalovirus (CMV) Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cytomegalovirus (CMV) Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cytomegalovirus (CMV) Diagnostic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cytomegalovirus (CMV) Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cytomegalovirus (CMV) Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cytomegalovirus (CMV) Diagnostic Market Report

Report Metric	Details
Report Name	Cytomegalovirus (CMV) Diagnostic Market
Accounted market size in 2024	US$ 830 in million
Forecasted market size in 2030	US$ 1170.7 million
CAGR	5.9
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Blood Urine
Segment by Application	Hospitals Diagnostic Centers and Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, bioMérieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cytomegalovirus (CMV) Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytomegalovirus (CMV) Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytomegalovirus (CMV) Diagnostic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Cytomegalovirus (CMV) Diagnostic Market growing?

Ans: The Cytomegalovirus (CMV) Diagnostic Market witnessing a CAGR of 5.9 during the forecast period 2024-2030.

What is the Cytomegalovirus (CMV) Diagnostic Market size in 2030?

Ans: The Cytomegalovirus (CMV) Diagnostic Market size in 2030 will be US$ 1170.7 million.

Who are the main players in the Cytomegalovirus (CMV) Diagnostic Market report?

Ans: The main players in the Cytomegalovirus (CMV) Diagnostic Market are Abbott Laboratories, bioMérieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech

What are the Application segmentation covered in the Cytomegalovirus (CMV) Diagnostic Market report?

Ans: The Applications covered in the Cytomegalovirus (CMV) Diagnostic Market report are Hospitals, Diagnostic Centers and Clinics, Others

What are the Type segmentation covered in the Cytomegalovirus (CMV) Diagnostic Market report?

Ans: The Types covered in the Cytomegalovirus (CMV) Diagnostic Market report are Blood, Urine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Blood

1.2.3 Urine

1.3 Market by Application

1.3.1 Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Diagnostic Centers and Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cytomegalovirus (CMV) Diagnostic Market Perspective (2019-2030)

2.2 Global Cytomegalovirus (CMV) Diagnostic Growth Trends by Region

2.2.1 Cytomegalovirus (CMV) Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cytomegalovirus (CMV) Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Cytomegalovirus (CMV) Diagnostic Market Dynamics

2.3.1 Cytomegalovirus (CMV) Diagnostic Industry Trends

2.3.2 Cytomegalovirus (CMV) Diagnostic Market Drivers

2.3.3 Cytomegalovirus (CMV) Diagnostic Market Challenges

2.3.4 Cytomegalovirus (CMV) Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cytomegalovirus (CMV) Diagnostic by Players

3.1.1 Global Cytomegalovirus (CMV) Diagnostic Revenue by Players (2019-2024)

3.1.2 Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Cytomegalovirus (CMV) Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cytomegalovirus (CMV) Diagnostic, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Cytomegalovirus (CMV) Diagnostic Market Concentration Ratio

3.4.1 Global Cytomegalovirus (CMV) Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus (CMV) Diagnostic Revenue in 2023

3.5 Global Key Players of Cytomegalovirus (CMV) Diagnostic Head office and Area Served

3.6 Global Key Players of Cytomegalovirus (CMV) Diagnostic, Product and Application

3.7 Global Key Players of Cytomegalovirus (CMV) Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cytomegalovirus (CMV) Diagnostic Breakdown Data by Type

4.1 Global Cytomegalovirus (CMV) Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Type (2025-2030)

5 Cytomegalovirus (CMV) Diagnostic Breakdown Data by Application

5.1 Global Cytomegalovirus (CMV) Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cytomegalovirus (CMV) Diagnostic Market Size (2019-2030)

6.2 North America Cytomegalovirus (CMV) Diagnostic Market Size by Type

6.2.1 North America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024)

6.2.2 North America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030)

6.2.3 North America Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

6.3 North America Cytomegalovirus (CMV) Diagnostic Market Size by Application

6.3.1 North America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024)

6.3.2 North America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030)

6.3.3 North America Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

6.4 North America Cytomegalovirus (CMV) Diagnostic Market Size by Country

6.4.1 North America Cytomegalovirus (CMV) Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2019-2024)

6.4.3 North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Cytomegalovirus (CMV) Diagnostic Market Size (2019-2030)

7.2 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Type

7.2.1 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024)

7.2.2 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030)

7.2.3 Europe Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

7.3 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Application

7.3.1 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024)

7.3.2 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030)

7.3.3 Europe Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

7.4 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country

7.4.1 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2019-2024)

7.4.3 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cytomegalovirus (CMV) Diagnostic Market Size (2019-2030)

8.2 China Cytomegalovirus (CMV) Diagnostic Market Size by Type

8.2.1 China Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024)

8.2.2 China Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030)

8.2.3 China Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

8.3 China Cytomegalovirus (CMV) Diagnostic Market Size by Application

8.3.1 China Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024)

8.3.2 China Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030)

8.3.3 China Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cytomegalovirus (CMV) Diagnostic Market Size (2019-2030)

9.2 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Type

9.2.1 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024)

9.2.2 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030)

9.2.3 Asia Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

9.3 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Application

9.3.1 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024)

9.3.2 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030)

9.3.3 Asia Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

9.4 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Region

9.4.1 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Region (2019-2024)

9.4.3 Asia Cytomegalovirus (CMV) Diagnostic Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Cytomegalovirus (CMV) Diagnostic Introduction

11.1.4 Abbott Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.1.5 Abbott Laboratories Recent Developments

11.2 bioMérieux

11.2.1 bioMérieux Company Details

11.2.2 bioMérieux Business Overview

11.2.3 bioMérieux Cytomegalovirus (CMV) Diagnostic Introduction

11.2.4 bioMérieux Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.2.5 bioMérieux Recent Developments

11.3 BD Biosciences

11.3.1 BD Biosciences Company Details

11.3.2 BD Biosciences Business Overview

11.3.3 BD Biosciences Cytomegalovirus (CMV) Diagnostic Introduction

11.3.4 BD Biosciences Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.3.5 BD Biosciences Recent Developments

11.4 Bio-Rad Laboratories

11.4.1 Bio-Rad Laboratories Company Details

11.4.2 Bio-Rad Laboratories Business Overview

11.4.3 Bio-Rad Laboratories Cytomegalovirus (CMV) Diagnostic Introduction

11.4.4 Bio-Rad Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.4.5 Bio-Rad Laboratories Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Cytomegalovirus (CMV) Diagnostic Introduction

11.5.4 Roche Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.5.5 Roche Recent Developments

11.6 Bioneer Corp

11.6.1 Bioneer Corp Company Details

11.6.2 Bioneer Corp Business Overview

11.6.3 Bioneer Corp Cytomegalovirus (CMV) Diagnostic Introduction

11.6.4 Bioneer Corp Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.6.5 Bioneer Corp Recent Developments

11.7 Siemens Healthcare

11.7.1 Siemens Healthcare Company Details

11.7.2 Siemens Healthcare Business Overview

11.7.3 Siemens Healthcare Cytomegalovirus (CMV) Diagnostic Introduction

11.7.4 Siemens Healthcare Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.7.5 Siemens Healthcare Recent Developments

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Details

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific Cytomegalovirus (CMV) Diagnostic Introduction

11.8.4 Thermo Fisher Scientific Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.8.5 Thermo Fisher Scientific Recent Developments

11.9 Realstar Group

11.9.1 Realstar Group Company Details

11.9.2 Realstar Group Business Overview

11.9.3 Realstar Group Cytomegalovirus (CMV) Diagnostic Introduction

11.9.4 Realstar Group Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.9.5 Realstar Group Recent Developments

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Cytomegalovirus (CMV) Diagnostic Introduction

11.10.4 Merck Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.10.5 Merck Recent Developments

11.11 Qiagen

11.11.1 Qiagen Company Details

11.11.2 Qiagen Business Overview

11.11.3 Qiagen Cytomegalovirus (CMV) Diagnostic Introduction

11.11.4 Qiagen Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.11.5 Qiagen Recent Developments

11.12 Guangdong Hybribio

11.12.1 Guangdong Hybribio Company Details

11.12.2 Guangdong Hybribio Business Overview

11.12.3 Guangdong Hybribio Cytomegalovirus (CMV) Diagnostic Introduction

11.12.4 Guangdong Hybribio Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.12.5 Guangdong Hybribio Recent Developments

11.13 Sansure Biotech

11.13.1 Sansure Biotech Company Details

11.13.2 Sansure Biotech Business Overview

11.13.3 Sansure Biotech Cytomegalovirus (CMV) Diagnostic Introduction

11.13.4 Sansure Biotech Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

11.13.5 Sansure Biotech Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Blood

Table 3. Key Players of Urine

Table 4. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cytomegalovirus (CMV) Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region (2019-2024)

Table 8. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region (2025-2030)

Table 10. Cytomegalovirus (CMV) Diagnostic Market Trends

Table 11. Cytomegalovirus (CMV) Diagnostic Market Drivers

Table 12. Cytomegalovirus (CMV) Diagnostic Market Challenges

Table 13. Cytomegalovirus (CMV) Diagnostic Market Restraints

Table 14. Global Cytomegalovirus (CMV) Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cytomegalovirus (CMV) Diagnostic Revenue Share by Players (2019-2024)

Table 16. Global Top Cytomegalovirus (CMV) Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Diagnostic as of 2023)

Table 17. Global Cytomegalovirus (CMV) Diagnostic Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Cytomegalovirus (CMV) Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Headquarters and Area Served

Table 20. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Product and Application

Table 21. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Type (2019-2024)

Table 25. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Type (2025-2030)

Table 27. Global Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cytomegalovirus (CMV) Diagnostic Revenue Share by Application (2019-2024)

Table 29. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cytomegalovirus (CMV) Diagnostic Revenue Share by Application (2025-2030)

Table 31. North America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Cytomegalovirus (CMV) Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Cytomegalovirus (CMV) Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Cytomegalovirus (CMV) Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Cytomegalovirus (CMV) Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Cytomegalovirus (CMV) Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 63. Abbott Laboratories Company Details

Table 64. Abbott Laboratories Business Overview

Table 65. Abbott Laboratories Cytomegalovirus (CMV) Diagnostic Product

Table 66. Abbott Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 67. Abbott Laboratories Recent Developments

Table 68. bioMérieux Company Details

Table 69. bioMérieux Business Overview

Table 70. bioMérieux Cytomegalovirus (CMV) Diagnostic Product

Table 71. bioMérieux Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 72. bioMérieux Recent Developments

Table 73. BD Biosciences Company Details

Table 74. BD Biosciences Business Overview

Table 75. BD Biosciences Cytomegalovirus (CMV) Diagnostic Product

Table 76. BD Biosciences Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 77. BD Biosciences Recent Developments

Table 78. Bio-Rad Laboratories Company Details

Table 79. Bio-Rad Laboratories Business Overview

Table 80. Bio-Rad Laboratories Cytomegalovirus (CMV) Diagnostic Product

Table 81. Bio-Rad Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 82. Bio-Rad Laboratories Recent Developments

Table 83. Roche Company Details

Table 84. Roche Business Overview

Table 85. Roche Cytomegalovirus (CMV) Diagnostic Product

Table 86. Roche Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 87. Roche Recent Developments

Table 88. Bioneer Corp Company Details

Table 89. Bioneer Corp Business Overview

Table 90. Bioneer Corp Cytomegalovirus (CMV) Diagnostic Product

Table 91. Bioneer Corp Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 92. Bioneer Corp Recent Developments

Table 93. Siemens Healthcare Company Details

Table 94. Siemens Healthcare Business Overview

Table 95. Siemens Healthcare Cytomegalovirus (CMV) Diagnostic Product

Table 96. Siemens Healthcare Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 97. Siemens Healthcare Recent Developments

Table 98. Thermo Fisher Scientific Company Details

Table 99. Thermo Fisher Scientific Business Overview

Table 100. Thermo Fisher Scientific Cytomegalovirus (CMV) Diagnostic Product

Table 101. Thermo Fisher Scientific Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 102. Thermo Fisher Scientific Recent Developments

Table 103. Realstar Group Company Details

Table 104. Realstar Group Business Overview

Table 105. Realstar Group Cytomegalovirus (CMV) Diagnostic Product

Table 106. Realstar Group Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 107. Realstar Group Recent Developments

Table 108. Merck Company Details

Table 109. Merck Business Overview

Table 110. Merck Cytomegalovirus (CMV) Diagnostic Product

Table 111. Merck Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 112. Merck Recent Developments

Table 113. Qiagen Company Details

Table 114. Qiagen Business Overview

Table 115. Qiagen Cytomegalovirus (CMV) Diagnostic Product

Table 116. Qiagen Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 117. Qiagen Recent Developments

Table 118. Guangdong Hybribio Company Details

Table 119. Guangdong Hybribio Business Overview

Table 120. Guangdong Hybribio Cytomegalovirus (CMV) Diagnostic Product

Table 121. Guangdong Hybribio Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 122. Guangdong Hybribio Recent Developments

Table 123. Sansure Biotech Company Details

Table 124. Sansure Biotech Business Overview

Table 125. Sansure Biotech Cytomegalovirus (CMV) Diagnostic Product

Table 126. Sansure Biotech Revenue in Cytomegalovirus (CMV) Diagnostic Business (2019-2024) & (US$ Million)

Table 127. Sansure Biotech Recent Developments

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cytomegalovirus (CMV) Diagnostic Market Share by Type: 2023 VS 2030

Figure 3. Blood Features

Figure 4. Urine Features

Figure 5. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Cytomegalovirus (CMV) Diagnostic Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Diagnostic Centers and Clinics Case Studies

Figure 9. Others Case Studies

Figure 10. Cytomegalovirus (CMV) Diagnostic Report Years Considered

Figure 11. Global Cytomegalovirus (CMV) Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Cytomegalovirus (CMV) Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region: 2023 VS 2030

Figure 14. Global Cytomegalovirus (CMV) Diagnostic Market Share by Players in 2023

Figure 15. Global Top Cytomegalovirus (CMV) Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Diagnostic as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Cytomegalovirus (CMV) Diagnostic Revenue in 2023

Figure 17. North America Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

Figure 19. North America Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

Figure 20. North America Cytomegalovirus (CMV) Diagnostic Market Share by Country (2019-2030)

Figure 21. United States Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cytomegalovirus (CMV) Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

Figure 25. Europe Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

Figure 26. Europe Cytomegalovirus (CMV) Diagnostic Market Share by Country (2019-2030)

Figure 27. Germany Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Cytomegalovirus (CMV) Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

Figure 35. China Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

Figure 36. Asia Cytomegalovirus (CMV) Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

Figure 38. Asia Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

Figure 39. Asia Cytomegalovirus (CMV) Diagnostic Market Share by Region (2019-2030)

Figure 40. Japan Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Cytomegalovirus (CMV) Diagnostic Market Share by Country (2019-2030)

Figure 50. Brazil Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Abbott Laboratories Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 57. bioMérieux Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 58. BD Biosciences Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 60. Roche Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 61. Bioneer Corp Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 62. Siemens Healthcare Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 64. Realstar Group Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 65. Merck Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 66. Qiagen Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 67. Guangdong Hybribio Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 68. Sansure Biotech Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-34D11827

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Vaccine Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-35Z7701

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Pediatric Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Brucella Melitensis Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-27A12787

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cytomegalovirus (CMV) Diagnostic Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-33G4546

Global Cytomegalovirus (CMV) Diagnostic Market Insights, Forecast to 2030

FEATURED COMPANIES

Cytomegalovirus (CMV) Diagnostic Market Size

Cytomegalovirus (CMV) Diagnostic Market

Scope of Cytomegalovirus (CMV) Diagnostic Market Report

Chapter Outline

FAQ for this report

How fast is Cytomegalovirus (CMV) Diagnostic Market growing?

What is the Cytomegalovirus (CMV) Diagnostic Market size in 2030?

Who are the main players in the Cytomegalovirus (CMV) Diagnostic Market report?

What are the Application segmentation covered in the Cytomegalovirus (CMV) Diagnostic Market report?

What are the Type segmentation covered in the Cytomegalovirus (CMV) Diagnostic Market report?

FEATURED COMPANIES

RELATED REPORTS